Dr. P. Kamala Subhashini, Dr. K. Sankar, Dr. Chandrakala Kambar, Dr.V.VenkataRamana “Comparative Study Of Efficacy and Safety of Topical Active Fragment of Basic Fibroblast Growth Factor (B FGF) 0.1% Solution V/S Betamethasone Valerate 0.1% Ointment in the Treatment of Vitiligo Patients” Journal of Dental and Medical Sciences (IOSR-JDMS) Volume 14, Issue 6 Ver. VIII (Jun. 2015), PP 41-47.

    Jesse M. Jaynes, V. Siva Rami Reddy. "GENOPEP", a Topical Cream in the Treatment of Burn Wounds. Small Wonders: Peptides for Disease Control, Chapter 8, 2012, pp 173-192.

    Charles P. Chalekson, Michael W. Neumeister, and Jesse Jaynes. Treatment of Infected Wounds with the Antimicrobial Peptide D2A21. The Journal of TRAUMA Injury, Infection, and Critical Care, 2002, DOI: 10.1097/01.

    Jia Ma, Suzanne Kennedy-Stoskopf, Jesse M. Jaynes, Linda M. Thurmond, and Wayne A. Tompkins. "Inhibitory Activity of Synthetic Peptide Antibiotics on Feline Immunodeficiency Virus Infectivity In Vitro" JOURNAL OF VIROLOGY, Oct. 2002, p. 9952-9961

    M. Ballweber, J. E. Jaynes, W. E. Stamm, and M. F. Lampe "In Vitro Microbicidal Activities of Cecropin Peptides D2A21 and D4E1 and Gel Formulations Containing 0.1 to 2% D2A21against Chlamydia trachomatis" Antimicrobial Agents And Chemotherapy, 2002, DOI: 10.1128/AAC.46.1.34-41.

    Julie A. Arlotti, B.S., Tami S. Cimino, B.S., Thu-Suong Nguyen, B.S., Rajiv Dhir, M.D., Angela Thomas, B.S., Jesse M. Jaynes, Ph.D., A. Lee Caldwell Jr., Ph.D., Robert H. Getzenberg, Ph.D. "Efficacy of a synthetic lytic peptide in the treatment of prostate cancer" Urologic Oncology 6 (2001) 97-102

    B. LUSHBAUGH, A. C. BLOSSOM, P. H. SHAH, A. K. BANGA, J. M. JAYNES, J. D. CLEARY, AND R. W. FINLEY. USE OF "INTRAVAGINAL MICROBICIDES TO PREVENT ACQUISITION OF TRICHOMONAS VAGINALIS INFECTION IN LACTOBACILLUS-PRETREATED, ESTROGENIZED YOUNG MICE". Am. J. Trop. Med. Hyg., 63(5, 6), 2000, pp. 284-289

    Charles P. Chalekson, Michael W. Neumeister , Jesse Jaynes. Improvement in Burn Wound Infection and Survival with Antimicrobial Peptide D2A21 (Demegel), Antimicrobial Peptide, Sep-2000, vol. 109, No. 4.

    Ute Schwab, Peter Gilligan, Jesse Jaynes, David Henke. In Vitro Activities of Designed Antimicrobial peptides against Multidrug-Resistant Cystic Fibrosis Pathogens. Antimicrobial Agents and Chemotherapy, June 1999, Vol. 43, p. 1435-1440.

    Cary N. Robertson, Kathryn M. Roberson, Aaron Pinero, Jesse M. Jaynes, David F. Paulson. Peptidyl membrane-interactive molecules are cytotoxic to prostatic cancer cells in vitro. World J Urol (1998) 16: 405-409